5?-CpG Island Methylation of the FHIT Gene is Associated with Reduced Protein Expression and Higher Clinical Stage in Cervical Carcinomas
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Ultrastructural Pathology
- Vol. 27 (6) , 417-422
Abstract
Aberrant transcription of the FHIT gene has been observed in many solid tumors, suggesting that 5'-CpG island methylation of the FHIT gene is involved in tumor development. The authors investigated the status of the 5'-CpG island methylation of the FHIT gene and protein expression in a series of 40 cervical carcinomas and 10 normal cervical epithelial samples, and correlated the data with clinicopathological findings. Methylation-specific PCR was applied to detect the incidence of the 5'-CpG island methylation, and immunohistochemistry was used for FHIT protein staining. 5'-CpG island methylation of the FHIT gene was detected in 40% (16/40) of the cervical cancer samples and in none of normal cervical epithelial specimens. Furthermore, the 5'-CpG island methylation was positively associated with clinical stage ( p =.002). All the normal cervical epithelial samples (10/10) and 90% (36/40) of the cervical carcinomas were positive when the unmethylated primer pair was applied. Of the 16 cervical carcinomas with 5'-CpG island methylation of the FHIT gene by PCR, 15 showed reduced FHIT protein expression. This study suggests that 5'-CpG island methylation plays an important role in inactivation of the FHIT gene in cervical cancer.Keywords
This publication has 16 references indexed in Scilit:
- FHIT: from gene discovery to cancer treatment and preventionThe Lancet Oncology, 2002
- FHITas Tumor Suppressor: Mechanisms and Therapeutic OpportunitiesCancer Biology & Therapy, 2002
- Restoration of fragile histidine triad ( FHIT ) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell linesProceedings of the National Academy of Sciences, 2002
- Characterization of aberrant FHIT transcripts in gastric adenocarcinomasExperimental & Molecular Medicine, 2001
- FHIT (Fragile Histidine Triad) Gene Analysis in Cervical Intraepithelial NeoplasiaGynecologic Oncology, 2001
- Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursOncogene, 2001
- The Tumor Suppressor Protein FhitJournal of Biological Chemistry, 1999
- Correlation between methylation status of thep16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancersInternational Journal of Cancer, 1998
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996